Solar urticaria, a disease with many dark sides: is omalizumab the right therapeutic response? Reflections from a clinical case report
Solar urticaria is a rare type of photodermatosis that significantly reduces the quality of life of the subjects affected, with a risk of anaphylaxis should the entire body be exposed to the sun. Patients are forced to modify and limit their normal activities, and since the symptoms are triggered by...
Main Authors: | De Martinis Massimo, Sirufo Maria Maddalena, Ginaldi Lia |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2019-06-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2019-0042 |
Similar Items
-
Successful Treatment With Omalizumab in a Child With Asthma and Urticaria: A Clinical Case Report
by: Maria Maddalena Sirufo, et al.
Published: (2019-06-01) -
Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016-02-01) -
Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
by: Ilya Ivyanskiy, et al.
Published: (2012-01-01) -
Omalizumab for treatment of chronic urticaria: A review of effective dose
by: javad Ghaffari, et al.
Published: (2019-03-01) -
Does Allergy Break Bones? Osteoporosis and Its Connection to Allergy
by: Maria Maddalena Sirufo, et al.
Published: (2020-01-01)